Mar. 11 at 8:19 PM
$BTMD Q4 '25 Earnings Results & Recap
• Reported GAAP EPS of
$0.06 down -50.00% YoY
• Reported revenue of
$46.41M down -6.87% YoY
• Biote anticipates 2026 revenue above
$190M and Adjusted EBITDA above
$38M. Procedure revenue is expected to return to growth in the second half of 2026, following a first-half decrease.